Literature DB >> 7423500

A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride.

M W Anderson, D G Hoel, N L Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7423500     DOI: 10.1016/0041-008x(80)90231-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  7 in total

1.  Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouse.

Authors:  B G Reigner; J F Rigod; T N Tozer
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

2.  Incorporation of biological information in cancer risk assessment: example--vinyl chloride.

Authors:  C W Chen; J N Blancato
Journal:  Cell Biol Toxicol       Date:  1989-12       Impact factor: 6.691

3.  Inhalation pharmacokinetics based on gas uptake studies. III. A pharmacokinetic assessment in man of "peak concentrations" of vinyl chloride.

Authors:  H M Bolt; J G Filser; A Buchter
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

4.  Implications of pharmacokinetic modeling in risk assessment analysis.

Authors:  R J Lutz; R L Dedrick
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

Review 5.  Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

Authors: 
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

6.  Extrapolation of animal carcinogenicity data: limitations and pitfalls.

Authors:  M D Hogan
Journal:  Environ Health Perspect       Date:  1983-01       Impact factor: 9.031

Review 7.  Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.

Authors:  G Goodman; R Wilson
Journal:  Environ Health Perspect       Date:  1991-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.